Affinity under threat from split

The mutual benefits to be gained from affinity cards cannot be doubted. Some 30m so far generated for good causes such as Oxfam, the RSPCA and NSPCC is eloquent testimony of what the cards can do for charities. All the more so when the harsh competitive environment they face is taken into consideration.

Somewhat less widely known, but no less impressive, is the money-spinning performance of these cards for their financial providers. Well-documented research demonstrates that properly targeted affinity cards have an edge over comparable credit cards in the frequency with which they are used and the number of monthly purchases their owners make. To say nothing of the intangible benefits of good publicity and enhanced customer loyalty that accrue.

But what happens when the relationship between card provider and good cause sours? The festering unpleasantness between the Halifax and Mencap over windfall shares is an excellent case in point. What had been a prosperous and successful relationship, stretching back nine years, is being jeopardised by the backlash from the Halifax’s incorporation as a bank. Specifically, it chose not to compensate immediately those people with accounts held in trust, of which the disabled comprise the largest number. As far as can be judged, the Halifax’s motives were governed by robust commercial logic; certainly it had the law on its side, at the time.

Mencap, meanwhile, was left in an impossible situation. Either it rolled over and was reviled for prostituting itself, or adopted a stance of high principle and risked losing a significant stream of income. In the event, Mencap’s trustees went for the high principle, high-risk route.

Incredibly, they look like losing the money. As the deadline draws close after 18 months of bickering, the Halifax shows no sign of offering significant compensation. It’s hard to see what the bank gains from this intransigence – beyond an unenviable reputation for meanness and cynicism. The expected outcome may also force the British Heart Foundation and the Imperial Cancer Research Fund – the other partners in this otherwise successful affinity scheme – to take a critical stance, although they are understandably reluctant to do so.

That said, Mencap has occupied relatively favourable terrain from which to wage its campaign. The vast majority of its income comes not from voluntary contributions but trading fees and contracts. Not many charities are so financially independent. In that sense, the Halifax is unlucky to have received such bad publicity.

Cover story, page 28

Latest from Marketing Week


Access Marketing Week’s wealth of insight, analysis and opinion that will help you do your job better.

Register and receive the best content from the only UK title 100% dedicated to serving marketers' needs.

We’ll ask you just a few questions about what you do and where you work. The more we know about our visitors, the better and more relevant content we can provide for them. And, yes, knowing our audience better helps us find commercial partners too. Don't worry, we won't share your information with other parties, unless you give us permission to do so.

Register now


Our award winning editorial team (PPA Digital Brand of the Year) ask the big questions about the biggest issues on everything from strategy through to execution to help you navigate the fast moving modern marketing landscape.


From the opportunities and challenges of emerging technology to the need for greater effectiveness, from the challenge of measurement to building a marketing team fit for the future, we are your guide.


Information, inspiration and advice from the marketing world and beyond that will help you develop as a marketer and as a leader.

Having problems?

Contact us on +44 (0)20 7292 3703 or email

If you are looking for our Jobs site, please click here